Show item record

dc.contributor.authorYtrebø, Lars M.
dc.contributor.authorKristiansen, Rune
dc.contributor.authorMaehre, Hanne
dc.contributor.authorFuskevåg, Ole-Martin
dc.contributor.authorKalstad, Trine
dc.contributor.authorRevhaug, Arthur
dc.contributor.authorJalan, Rajiv
dc.contributor.authorRose, Christopher
dc.date.accessioned2015-03-05T18:55:51Z
dc.date.available2015-03-05T18:55:51Z
dc.date.issued2009-07
dc.identifier.urihttp://hdl.handle.net/1866/11401
dc.subjectAmmoniafr
dc.subjectIntracranial Hypertensionfr
dc.subjectLiver Failurefr
dc.subjectOrnithinefr
dc.subjectPhenylacetatefr
dc.subjectAmmoniacfr
dc.subjectHypertension intracrâniennefr
dc.subjectDéfaillance hépatiquefr
dc.subjectPhénylacétatesfr
dc.titleL-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure
dc.typeArticlefr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecine. Centre de recherche du CHUMfr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecinefr
dc.identifier.doi10.1002/hep.22917
dcterms.abstractHyperammonemia is a feature of acute liver failure (ALF), which is associated with increased intracranial pressure (ICP) and brain herniation. We hypothesized that a combination of L-ornithine and phenylacetate (OP) would synergistically reduce toxic levels of ammonia by (1) L-ornithine increasing glutamine production (ammonia removal) through muscle glutamine synthetase and (2) phenylacetate conjugating with the ornithine-derived glutamine to form phenylacetylglutamine, which is excreted into the urine. The aims of this study were to determine the effect of OP on arterial and extracellular brain ammonia concentrations as well as ICP in pigs with ALF (induced by liver devascularization). ALF pigs were treated with OP (L-ornithine 0.07 g/kg/hour intravenously; phenylbutyrate, prodrug for phenylacetate; 0.05 g/kg/hour intraduodenally) for 8 hours following ALF induction. ICP was monitored throughout, and arterial and extracellular brain ammonia were measured along with phenylacetylglutamine in the urine. Compared with ALF + saline pigs, treatment with OP significantly attenuated concentrations of arterial ammonia (589.6 +/- 56.7 versus 365.2 +/- 60.4 mumol/L [mean +/- SEM], P= 0.002) and extracellular brain ammonia (P= 0.01). The ALF-induced increase in ICP was prevented in ALF + OP-treated pigs (18.3 +/- 1.3 mmHg in ALF + saline versus 10.3 +/- 1.1 mmHg in ALF + OP-treated pigs;P= 0.001). The value of ICP significantly correlated with the concentration of extracellular brain ammonia (r(2) = 0.36,P< 0.001). Urine phenylacetylglutamine levels increased to 4.9 +/- 0.6 micromol/L in ALF + OP-treated pigs versus 0.5 +/- 0.04 micromol/L in ALF + saline-treated pigs (P< 0.001).Conclusion:L-Ornithine and phenylacetate act synergistically to successfully attenuate increases in arterial ammonia, which is accompanied by a significant decrease in extracellular brain ammonia and prevention of intracranial hypertension in pigs with ALF.fr
dcterms.languageengfr
UdeM.VersionRioxxVersion acceptée / Accepted Manuscript
oaire.citationTitleHepatology
oaire.citationVolume50
oaire.citationIssue1
oaire.citationStartPage165
oaire.citationEndPage174


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.